Table 4.
Interval changes of the LANSS, VAS-N, VAS-A, NDI, and EQ-5D scores after the first 4 weeks and during the next 4 weeks.
| Opioid-only group | Pregabalin add-on group | p-value | |
|---|---|---|---|
| LANSS | |||
| From baseline to 4 weeks | 2.9 ± 3.5 | 6.2 ± 2.8 | 0.005 |
| From 4 weeks to 8 weeks | 2.4 ± 4.0 | 3.3 ± 2.5 | 0.615 |
| VAS-N | |||
| From baseline to 4 weeks | 2.8 ± 1.7 | 4.7 ± 1.6 | 0.001 |
| From 4 weeks to 8 weeks | 1.8 ± 1.3 | 2.2 ± 1.0 | 0.377 |
| VAS-A | |||
| From baseline to 4 weeks | 2.8 ± 1.5 | 4.1 ± 1.6 | 0.035 |
| From 4 weeks to 8 weeks | 1.9 ± 1.9 | 1.7 ± 1.5 | 0.716 |
| NDI | |||
| From baseline to 4 weeks | 4.1 ± 8.7 | 5.5 ± 6.8 | 0.847 |
| From 4 weeks to 8 weeks | 3.3 ± 6.7 | 2.3 ± 5.9 | 0.279 |
| EQ-5D | |||
| From baseline to 4 weeks | 0.11 ± 0.14 | 0.08 ± 0.14 | 0.645 |
| From 4 weeks to 8 weeks | 0.09 ± 0.08 | 0.06 ± 0.12 | 0.765 |
Abbreviations: LANSS, Leeds assessment of neuropathic symptoms and signs; VAS-N, visual analogue scale for neck pain; VAS-A, visual analogue scale for arm pain; NDI, neck disability index; EQ-5D, EuroQol-5Dimension.
The values represent the means ± the standard deviations. Boldface type indicates statistical significance.